Cizumab 100 – Bevacizumab 100 mg/4 mL for B2B Supply
Cizumab 100 contains Bevacizumab 100 mg/4 mL, a prescription oncology medicine used under specialist medical supervision for certain cancers. For pharmaceutical distributors, licensed importers, hospitals, oncology procurement teams, and institutional buyers, sourcing injectable oncology medicines requires careful attention to product specifications, storage conditions, batch information, documentation, and destination-country regulations. Ernest Oncology, associated with Ernest Pharmaceutical Pvt. Ltd., India, supports professional B2B enquiries for Cizumab 100 and other specialty oncology medicines. For buyers searching for a Bevacizumab 100 mg supplier in Canberra or a Bevacizumab supplier in Abu Dhabi, our team can review product availability, required quantity, documentation needs, and feasible international supply arrangements.What Is Cizumab 100?
Cizumab 100 is an injectable formulation containing Bevacizumab 100 mg in 4 mL. Bevacizumab is a monoclonal antibody used as part of treatment protocols for certain cancers. It works by targeting vascular endothelial growth factor (VEGF), a protein involved in the formation of new blood vessels. Because tumors require a blood supply for growth, inhibiting VEGF-mediated angiogenesis is one mechanism through which bevacizumab is used in oncology treatment. The exact indication, combination therapy, dose, infusion schedule, and duration must be determined by a qualified oncology specialist.
Product Overview
| Product Detail | Information |
|---|---|
| Product Name | Cizumab 100 |
| Generic Name | Bevacizumab |
| Strength | 100 mg/4 mL |
| Dosage Form | Injection |
| Drug Category | Monoclonal Antibody / Oncology Medicine |
| Administration | Intravenous infusion under medical supervision |
| Procurement Type | B2B / Institutional Supply |
| Source Market | India |
| Target Locations | Canberra, Australia & Abu Dhabi, UAE |
Why Is Bevacizumab Used in Oncology?
Bevacizumab belongs to a group of medicines known as anti-angiogenic therapies. Rather than acting like conventional chemotherapy, it targets a biological pathway involved in tumor blood-vessel development.
Depending on the approved indication and treatment protocol, bevacizumab may be used in the management of certain cancers, potentially including colorectal, lung, kidney, ovarian and other cancers. However, indications differ by jurisdiction and product authorization. Buyers and healthcare professionals should therefore verify the approved prescribing information applicable to their market. Cizumab 100 is a prescription medicine and should only be administered under appropriate specialist supervision.
Bevacizumab 100 mg Supplier in Canberra
Healthcare procurement organizations searching for a Bevacizumab 100 mg supplier in Canberra may require more than basic product availability.
Institutional oncology procurement can involve verification of:
- Manufacturer and brand information
- Bevacizumab strength and presentation
- Available pack configuration
- Batch and expiry information
- Storage requirements
- Commercial quotation
- Supporting product documentation
- Export packaging requirements
- Shipment feasibility
Ernest Oncology supports B2B sourcing enquiries from eligible Australian pharmaceutical buyers, subject to applicable Australian import, regulatory and distribution requirements.
Bevacizumab Supplier in Abu Dhabi
For licensed buyers searching for a Bevacizumab supplier in Abu Dhabi, Ernest Oncology provides enquiry-based sourcing assistance for oncology medicines from India. Importers, pharmaceutical distributors, hospital procurement departments and other eligible organizations can submit their required quantity and purchasing specifications. Before commercial processing, product availability and applicable export requirements can be reviewed according to the enquiry and destination-market requirements.
B2B Bevacizumab Procurement from India
International oncology procurement is different from ordinary product purchasing. Buyers often need to evaluate the complete supply process rather than price alone. Ernest Oncology supports professional enquiries for Bevacizumab injection wholesale supply from India with attention to product identification, quantity, documentation, packing and shipment coordination.
A typical enquiry may follow:
B2B Enquiry → Requirement Review → Availability Check → Product & Pack Confirmation → Commercial Quotation → Documentation Review → Order Processing → Export Packing → Dispatch Coordination
This approach helps buyers obtain relevant commercial and product information before proceeding with an order.
Product Documentation Support
Documentation requirements can vary according to the manufacturer, product, shipment and destination.
Where applicable and available for the specific supply, buyers may request information relating to:
Commercial Invoice • Packing List • Batch Details • Expiry Details • Certificate of Analysis (CoA) • Manufacturer Information • Country of Origin documentation • Shipping Documentation
Additional regulatory documentation should be confirmed during the enquiry stage rather than assumed to be available for every order.
Storage & Handling Considerations
Bevacizumab is a biologic medicine, so correct storage and handling are important throughout the pharmaceutical supply chain. Storage conditions should always follow the approved manufacturer's product information. Buyers should confirm the required temperature conditions and logistics arrangements before shipment. Where temperature-controlled transportation is required, packaging and shipping feasibility should be evaluated according to the shipment route and destination requirements.
Who Can Send a B2B Enquiry?
Our oncology sourcing services are intended primarily for professional and institutional procurement, including:
Pharmaceutical Importers • Medicine Distributors • Licensed Wholesalers • Hospital Procurement Teams • Oncology Centres • Institutional Buyers • Authorized Healthcare Procurement Organizations
Supply remains subject to applicable prescription-medicine, import, distribution and regulatory requirements in the destination market.
What Should Buyers Include in Their RFQ?
To receive a more relevant quotation for Cizumab 100 wholesale supply, buyers should ideally provide:
Product: Cizumab 100 / Bevacizumab 100 mg/4 mL
Required Quantity: Number of units required
Destination: Country and delivery location
Buyer Type: Importer, distributor, hospital or institution
Documentation: Any specific regulatory or commercial documents required
Shipping Requirements: Any applicable temperature-control or logistics specifications
Providing these details at the beginning can make product availability and quotation review more efficient.
Frequently Asked Questions
1. What does Cizumab 100 contain?
Cizumab 100 contains Bevacizumab 100 mg/4 mL.
2. Is Bevacizumab an oncology medicine?
Yes. Bevacizumab is a monoclonal antibody used in oncology for certain approved cancer indications.
3. How does Bevacizumab work?
It targets VEGF, which is involved in angiogenesis—the development of new blood vessels.
4. Is Cizumab 100 intended for self-administration?
No. Bevacizumab injection requires appropriate medical supervision and is administered according to a specialist-prescribed treatment protocol.
5. Can pharmaceutical buyers request bulk quantities?
Eligible B2B buyers can submit their required quantity for an availability and commercial review.
6. Do you support Bevacizumab supply enquiries for Canberra?
Yes. Eligible buyers can submit B2B enquiries for Canberra, subject to applicable Australian regulations and import requirements.
7. Can buyers from Abu Dhabi request Cizumab 100?
Eligible pharmaceutical and institutional buyers can submit procurement enquiries, subject to applicable UAE requirements.
8. Can batch and expiry information be requested?
Yes. Buyers can request available batch and expiry details during procurement discussions.
9. Is a CoA available?
The availability of a Certificate of Analysis and other supporting documents should be confirmed for the specific batch and order.
10. How can I request a Bevacizumab wholesale quotation?
Send the required product, quantity, destination, buyer details and documentation requirements to Ernest Oncology for review.
Request a Cizumab 100 B2B Quotation
If your organization is searching for a Cizumab 100 supplier, Bevacizumab 100 mg/4 mL exporter from India, or Bevacizumab injection wholesale supplier, send your procurement requirement to Ernest Oncology. Providing the required quantity, destination and documentation needs allows the team to review availability and prepare relevant commercial and shipment information.
Ernest Oncology is an oncology-focused pharmaceutical sourcing channel associated with Ernest Pharmaceutical Pvt. Ltd., India.
Specialisation: Oncology & Specialty Pharmaceuticals
Business Model: B2B Pharmaceutical Sourcing & Export Support
Buyer Segment: Importers, Distributors, Wholesalers & Institutional Procurement
Source Market: India
